Leqselvi: payments to doctors
Payments that named Leqselvi as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $775K
- Providers
- 2,881
- Transactions
- 5,163
- Average per transaction
- $150
The per-transaction average — $150 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,881 providers the average total is $269, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| SUN Pharmaceutical Industries Inc. | $765,098 | 98.7% |
| Sun Pharmaceutical Industries Inc. | $9,807 | 1.3% |